News

Employee Spotlight: Maya Shimony

May 13, 2020 Employee Spotlight:  Maya Shimony, Lead Data Manager, TRiNDS Data Management All of us at the TRiNDS team come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to introduce Maya Shimony, Lead Data Manager in TRiNDS Data Management. We sat down with Maya… Read more »

Italfarmaco: Updates on Givinostat for Duchenne Muscular Dystrophy

April 27, 2020 TRiNDS is honored to work with clients from around the world working to develop investigational products for rare neuromuscular diseases. Today, one of our clients shared a press release about their progress. Italfarmaco Group has issued a press release (link: https://www.businesswire.com/news/home/20200427005274/en/Italfarmaco-Update-Advanced-Stage-Clinical-Development-Program-Givinostat) to provide an update on the clinical development program with Givinostat… Read more »

We Put the Pieces Togeter for Your Project

March 4, 2020 Clinical Operations in Rare Disease Managing clinical trials is always complicated. Trial sites are scattered around the world, protocols have complex requirements, and timelines are always tight. Clinical trials in rare disease populations have added complexity due to the nature of the diagnosis and its standard clinical care practices. Eligible rare disease… Read more »

Employee Spotlight – Ana Christensen

February 19, 2020 All of us at the TRiNDS team come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to introduce Ana Christensen, Lead Project Manager, Strategic Solutions. We sat down with Ana to learn more about her and her work. 1.  How did you… Read more »

Planning for Genetic Variability

February 5, 2020 At TRiNDS, we focus on the unique needs for companies conducting clinical trials in rare disease populations. Clinical trials are always challenging, but rare neuromuscular disorders add complexity to study design and execution. Many neuromuscular disorders have genetic causes, such as spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD). Unlike other… Read more »

Employee Spotlight: Caroline Bong, Clinical Research Intern

January 16, 2020 All of us at the TRiNDS team come to work every day committed to conducting the best quality rare disease and neuromuscular research.  Today we’d like to introduce Caroline Bong, Clinical Research Intern. We sat down with Caroline to learn more about her and her work. How did you come to work… Read more »

Expert Neuromuscular Research Support

January 8, 2020 TRiNDS offers a unique contract research organization (CRO) service model to clients conducting research and drug development for rare and neuromuscular disorders. Drug developers and researchers often can’t do everything in – house for every project – it’s too difficult to build the capacity needed to run, supervise, and analyze everything involved… Read more »

TRiNDS Data Management Services

December 4, 2019 While data is at the center of every research project, data management strategy and implementation can seem mysterious. Data management is more than just issuing queries and locking case report forms – it includes all the steps and systems that you’ll need to prevent user error, flag problems for rapid response, and… Read more »

Apply to Join the TRiNDS Team Today!

  October 30, 2019 TRiNDS has two job postings open at https://trinds.com/about-us/careers/. We are looking for a Clinical Research Data Manager to join the Data Management team to handle data for critical clinical trials and research studies for people living with rare diseases. We are also seeking a Clinical Research Project Manager to join the… Read more »

Dedicated to Rare Disease

September 11, 2019 TRiNDS is a neuromuscular and rare disease contract research organization (CRO). That means that our staffing, processes, and systems are designed with the unique needs of people with neuromuscular disorders and other rare diseases in mind. We know rare and orphan disease clinical trials face different struggles than those about more common… Read more »